Core A: Biospecimen Processing Core

Directors:

Meagan A. Jacoby, MD, PhD (WashU)

Mark A. Watson, MD, PhD (WashU)

The Biospecimen Processing Core (Core A) provides high-quality, clinically annotated biospecimens to all SPORE research projects and serves as a critical biospecimen resource to the broader leukemia research community.  This core is responsible for identifying and enrolling every consenting patient referred to the Siteman Cancer Center with a newly diagnosed hematologic malignancy (excluding multiple myeloma).  Biospecimens from these patients are collected at multiple timepoints, processed, cryopreserved, and stored for future studies.  Detailed clinical data associated with each patient and biospecimen collection timepoint are collected prospectively to facilitate future sample selection and correlative analyses.  This Core expands upon an existing CAP-accredited SCC biobank with additional, focused expertise, effort, and enabling technologies to comprehensively collect, annotate, process, quality review, and distribute biospecimens specifically for translational leukemia and leukemia-related cancer research.  A further description of biospecimen resources available to the broader research community can be found on the NCI Specimen Resource Locator.